Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 4
1988 10
1989 10
1990 11
1991 9
1992 18
1993 12
1994 14
1995 16
1996 17
1997 16
1998 16
1999 14
2000 20
2001 18
2002 33
2003 31
2004 35
2005 22
2006 26
2007 28
2008 20
2009 22
2010 8
2011 6
2012 9
2013 18
2014 12
2015 5
2016 7
2017 10
2018 7
2019 6
2020 7
2021 3
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

501 results
Results by year
Filters applied: . Clear all
Page 1
Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.
Yamprasert R, Chanvimalueng W, Mukkasombut N, Itharat A. Yamprasert R, et al. BMC Complement Med Ther. 2020 Apr 20;20(1):119. doi: 10.1186/s12906-020-2875-z. BMC Complement Med Ther. 2020. PMID: 32312261 Free PMC article. Clinical Trial.
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR patients were treated with ginger extract 500 mg (n = 40) against those treated with loratadine 10 mg (n = 40) in a randomized, double …
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR p …
Randomized, placebo-controlled study of cetirizine and loratadine in children with seasonal allergic rhinitis.
Nayak AS, Berger WE, LaForce CF, Urdaneta ER, Patel MK, Franklin KB, Wu MM. Nayak AS, et al. Allergy Asthma Proc. 2017 May 1;38(3):222-230. doi: 10.2500/aap.2017.38.4050. Allergy Asthma Proc. 2017. PMID: 28441993 Clinical Trial.
The differences in TSSC score improvement over 14 days between the cetirizine versus loratadine groups (-2.1 versus -1.8; p = 0.124) and between the loratadine versus placebo groups (-1.8 versus -1.6; p = 0.230) were not statistically significant. ...Symptom improve …
The differences in TSSC score improvement over 14 days between the cetirizine versus loratadine groups (-2.1 versus -1.8; p = 0.124) …
Brain histamine H1 receptor occupancy after oral administration of desloratadine and loratadine.
Nakamura T, Hiraoka K, Harada R, Matsuzawa T, Ishikawa Y, Funaki Y, Yoshikawa T, Tashiro M, Yanai K, Okamura N. Nakamura T, et al. Pharmacol Res Perspect. 2019 Jul 12;7(4):e00499. doi: 10.1002/prp2.499. eCollection 2019 Aug. Pharmacol Res Perspect. 2019. PMID: 31338198 Free PMC article. Clinical Trial.
The plasma concentration of loratadine was negatively correlated with BPR in subjects receiving loratadine, but that of desloratadine was not correlated with BPR. Brain H(1)ROs after desloratadine and loratadine administration were 6.47 10.5% and 13.8 7.00%, …
The plasma concentration of loratadine was negatively correlated with BPR in subjects receiving loratadine, but that of deslor …
Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis.
Ng CC, Romaikin D, Steacy LM, Stevens DA, Walker TJ, Adams DE, Ellis AK. Ng CC, et al. Ann Allergy Asthma Immunol. 2021 Sep;127(3):342-348.e2. doi: 10.1016/j.anai.2021.05.001. Epub 2021 May 14. Ann Allergy Asthma Immunol. 2021. PMID: 34000435 Free article. Clinical Trial.
OBJECTIVE: To evaluate, numerically, nasal airflow changes provided by a single dose of loratadine-pseudoephedrine tablet (LP) and fluticasone propionate nasal spray (FP) in participants experiencing allergic rhinitis symptoms, including nasal congestion. ...
OBJECTIVE: To evaluate, numerically, nasal airflow changes provided by a single dose of loratadine-pseudoephedrine tablet (LP) and fl …
NOLAN: a randomized, phase 2 study to estimate the effect of prophylactic naproxen or loratadine vs no prophylactic treatment on bone pain in patients with early-stage breast cancer receiving chemotherapy and pegfilgrastim.
Kirshner JJ, McDonald MC 3rd, Kruter F, Guinigundo AS, Vanni L, Maxwell CL, Reiner M, Upchurch TE, Garcia J, Morrow PK. Kirshner JJ, et al. Support Care Cancer. 2018 Apr;26(4):1323-1334. doi: 10.1007/s00520-017-3959-2. Epub 2017 Nov 16. Support Care Cancer. 2018. PMID: 29147854 Free PMC article. Clinical Trial.
Maximum, mean, and area under the curve for patient-reported bone pain were consistently lower in the naproxen and loratadine groups than in the no prophylaxis group; some of these differences were significant. Loratadine was associated with fewer treatment-related …
Maximum, mean, and area under the curve for patient-reported bone pain were consistently lower in the naproxen and loratadine groups …
Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial.
Druce HM, Thoden WR, Mure P, Furey SA, Lockhart EA, Xie T, Galant S, Prenner BM, Weinstein S, Ziering R, Brandon ML. Druce HM, et al. J Clin Pharmacol. 1998 Apr;38(4):382-9. doi: 10.1002/j.1552-4604.1998.tb04439.x. J Clin Pharmacol. 1998. PMID: 9590467 Clinical Trial.
Loratadine was significantly better than placebo for physician ratings of total symptom severity averaged over the two days and for the physician and subject ratings of the nasal cluster on day 3. ...A nonprescription, extended-release formulation of brompheniramine 12 mg …
Loratadine was significantly better than placebo for physician ratings of total symptom severity averaged over the two days and for t …
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Meltzer EO, et al. J Allergy Clin Immunol. 2000 May;105(5):917-22. doi: 10.1067/mai.2000.106040. J Allergy Clin Immunol. 2000. PMID: 10808172 Clinical Trial.
OBJECTIVE: The purpose of this study was to determine the effect of concomitant use of montelukast and loratadine in the treatment of seasonal allergic rhinitis. METHODS: In this multicenter (N = 12) double-blind, randomized, parallel-group, placebo-controlled 2-week trial …
OBJECTIVE: The purpose of this study was to determine the effect of concomitant use of montelukast and loratadine in the treatment of …
Loratadine augments emotional blushing.
Drummond PD, Lester B. Drummond PD, et al. Eur Neuropsychopharmacol. 2018 Nov;28(11):1284-1288. doi: 10.1016/j.euroneuro.2018.08.003. Epub 2018 Aug 26. Eur Neuropsychopharmacol. 2018. PMID: 30153954 Clinical Trial.
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would reduce emotional blushing. ...Increases in facial blood flow while participants sang were greater in the loratadine than the placebo …
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would …
Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S, Malice MP, Dass SB, Reiss TF. Lu S, et al. J Asthma. 2009 Nov;46(9):878-83. doi: 10.3109/02770900903104540. J Asthma. 2009. PMID: 19905912 Clinical Trial.
OBJECTIVE: We compared the efficacy of this combination versus placebo, nasal beclomethasone, montelukast, and loratadine in study 1 and versus placebo, montelukast, and loratadine in study 2. ...All treatments were significantly better than placebo; montelukast+ …
OBJECTIVE: We compared the efficacy of this combination versus placebo, nasal beclomethasone, montelukast, and loratadine in study 1 …
501 results